Navigation Links
Susan G. Komen for the Cure Announces Recipients of 2007 Komen Brinker Award for Scientific Distinction
Date:12/12/2007

University of Southern California, Lawrence Berkeley National Laboratory Pioneers Honored for Prevention Studies, Widely Adopted Innovations in

Biomedical Research

DALLAS, Dec. 13 /PRNewswire/ -- Susan G. Komen for the Cure, the global leader in the movement to end breast cancer forever, has announced the recipients of the 2007 Komen Brinker Award for Scientific Distinction, the organization's highest award of merit.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

This year's recipients are Leslie Bernstein, Ph.D., professor, department of preventive medicine and the inaugural holder of the AFLAC, Inc. Chair in Cancer Research at the University of Southern California, Los Angeles, and Joe W. Gray, Ph.D., director, division of life sciences, Lawrence Berkeley National Laboratory, Berkeley, Calif.

Dr. Bernstein and Dr. Gray will be formally recognized during the 30th annual San Antonio Breast Cancer Symposium (SABCS), a major international gathering of breast cancer researchers, clinicians and patient advocacy organizations, Dec. 13-16 in San Antonio. The two recipients will deliver lectures for SABCS attendees at 3:45 p.m. Dec. 13 in Exhibit Hall D of the Henry B. Gonzalez Convention Center. Both will receive cash awards of $25,000 and a crystal award.

The Art and Science of Delivering the Cures

The evening of Dec. 13, Susan G. Komen for the Cure founder Ambassador Nancy G. Brinker will be the featured speaker at a gala dinner held at the Gonzalez Center in honor of the Komen Brinker award recipients. In recognition of the art and the science involved in both research and clinical endeavors, Komen has themed the evening 'Toward a Culture of Discovery: Progress and Passion in the Search for the Cures.' Susan G. Komen for the Cure's Art for the Cure program, which features a special traveling
'/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... MX (PRWEB) September 18, 2014 September ... Mexico City, MX. ASEA is the manufacturer of the ... the skin care product, RENU28. , The Mexico ... Vice President Duvan Botero, and ASEA Field Leader Shawn ... holds a PhD in Atomic/Medical Physics from the University ...
(Date:9/17/2014)... - Oncothyreon Inc. (NASDAQ: ONTY ) today ... of its Common Stock and Series A Convertible Preferred ... Series A Convertible Preferred Stock is non-voting and convertible ... will be prohibited if, as a result, the holder ... of the Common Stock then outstanding. As part of ...
(Date:9/17/2014)... September 17, 2014 A biodegradable ... microorganisms such as bacteria, fungi, and algae into ... methane, biomass, inorganic compounds, carbon dioxide, and humus ... customer base and improved costs, biodegradable polymers are ... viable alternative to conventional polymers. Primary factors that ...
(Date:9/17/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... cost and predictability of non-adherence in type 2 diabetes ... the European Association for the Study of Diabetes (EASD). ... Ph.D., of Analysis Group, Inc. presented data from the ... to characterize the prevalence of non-adherence and serial non-adherence, ...
Breaking Biology Technology:Announcing the ASEA Mexico Grand Opening Tour Beginning September 18th 2Oncothyreon Announces Proposed Public Offerings 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5
... Pioneering medical device company Signostics announced today ... Food and Drug Administration (FDA) for its ... http://www.newscom.com/cgi-bin/prnh/20090519/SF19276 )Signostics has developed a cost-effective device ... affordable for individual health professionals to use ...
... Inc. (TSX:SBS), specializing in the manufacture of high-value ... encouraging data from the Company,s Apo AI(Milano) development ... SemBioSys, plant-derived Apo AI(Milano) has exhibited the appropriate ... plaque volume. , New data from two of ...
... NANJING, China, May 19 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(NYSE: ... of branded generic and,innovative anti-cancer pharmaceuticals in China, announced ... Officer. , Dr. Wang will ... and,innovative research projects. He will also participate in ...
Cached Biology Technology:Signostics Receives FDA Clearance for World's Smallest Ultrasound Product 2SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 2SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 3SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 4Simcere Pharmaceutical Group Appoints Dr. Peng Wang as Chief Scientific Officer 2
(Date:9/17/2014)... an EC-FP5 four-year project, delivering its first release in ... participations in several EC projects, as a part of ... (EU BON), to increase the general awareness of the ... general dissemination of the Fauna Europaea results, the ... novel e-Publishing tools to prepare data papers for all ...
(Date:9/17/2014)... plastic shopping bags and their environmental impact recently scored ... first statewide ban on the bags, and Governor Jerry ... bag industry is not yielding without a fight, according ... , the weekly newsmagazine of the American Chemical Society. ... that the anti-bag campaign logged its first small victory ...
(Date:9/17/2014)... have obtained the first partial genome sequence of an ... at the site of the Montsoriu Castle in Girona, ... closely related to today,s Iberian pig. Researchers also discard ... Iberian pigs. , The study, published in Heredity ... species, and particularly on that of the Iberian breed, ...
Breaking Biology News(10 mins):Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2Iberian pig genome remains unchanged after 5 centuries 2
... press release is available in German . ... at the Max Planck Institute for Developmental Biology in ... to identify neuronal correlates of behaviour by comparing maps ... different behaviour. They compared the pharyngeal nervous systems of ...
... had been in the business of trading wetlands rather than ... current guidelines for wetland restoration. Research from the University of ... over wetland restoration sites result in more environmentally positive outcomes. ... under the current policies if a wetland is scheduled for ...
... in The Journal of General Physiology ... results, indicating that the extracellular accumulation of potassium that ... thought. Muscle excitation involves the influx of sodium ... of ions that cross the muscle membrane with each ...
Cached Biology News:The neurobiological consequence of predating or grazing 2The neurobiological consequence of predating or grazing 3Trading wetlands no longer a deal with the devil 2Trading wetlands no longer a deal with the devil 3Study offers new insights into the mechanics of muscle fatigue 2
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: